Biopharmaceuticals

A biopharmaceutical product, also known as a biological (biological) or biological (biological) product, is any pharmaceutical drug product manufactured, extracted or semi-synthesized from biological sources. Different pharmaceutical products synthesized include vaccines, blood, blood components, allergens, somatic cells, gene therapies, tissues, recombinant therapeutic proteins and living cells used in cell therapy. Biological products can be composed of sugars, proteins or nucleic acids or complex combinations of these substances or may be living cells or tissues. They (or their precursors or components) are isolated from living sources - human, animal, plant, fungal or microbial.

The terminology surrounding biopharmaceuticals varies between groups and entities, with different terms referring to different subsets of therapeutics in the general biopharmaceutical category. Some regulators use the terms "biological drugs" or "therapeutic biologics" to refer specifically to macromolecular products manufactured such as protein and nucleic acid drugs, distinguishing them from products such as blood, blood components Or vaccines, Biological. Specialty drugs, a recent classification of pharmaceuticals, are high-priced drugs that are often biologics.

  • Vaccines
  • Gene therapy
  • Biosimilars
  • recombinant DNA technology
  • Xenobiotics
  • Applied Biopharmaceutics
  • Array of Clinical Trials in Biopharmaceutics
  • Biologic Drugs
  • Biological Medicine
  • Biowaiver
  • Regulatory Sciences
  • Protein Interactions as Targeted Therapeutics
  • Nanoparticles-An Innovative Drug Delivery System
  • Interpenetrating Polymer Network as DDS
  • Herbal Drug Interactions
  • Biopharmaceutical Companies & Market Analysis
  • Generic drugs
  • Biogenomic in emergency medicine

Biopharmaceuticals Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in